sunny.png
Sunday October 24th, 2021 11:33AM

Merck asks US FDA to authorize promising anti-COVID pill

By The Associated Press

WASHINGTON (AP) — Drugmaker Merck asked U.S. regulators Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.

If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat the illness. All other FDA-backed treatments against COVID-19 require an IV or injection.

An antiviral pill that people could take at home to reduce their symptoms and speed recovery could prove groundbreaking, easing the crushing caseload on U.S. hospitals and helping to curb outbreaks in poorer countries with weak health care systems. It would also bolster the two-pronged approach to the pandemic: treatment, by way of medication, and prevention, primarily through vaccinations.

The FDA will scrutinize company data on the safety and effectiveness of the drug, molnupiravir, before rendering a decision.

Merck and its partner Ridgeback Biotherapeutic said they specifically asked the agency to grant emergency use for adults with mild-to-moderate COVID-19 who are at risk for severe disease or hospitalization. That is roughly the way COVID-19 infusion drugs are used.

“The value here is that it’s a pill so you don’t have to deal with the infusion centers and all the factors around that,” said Dr. Nicholas Kartsonis, a senior vice president with Merck's infectious disease unit. “I think it's a very powerful tool to add to the toolbox.”

The company reported earlier this month that the pill cut hospitalizations and deaths by half among patients with early symptoms of COVID-19. The results were so strong that independent medical experts monitoring the trial recommended stopping it early.

Side effects were similar between patients who got the drug and those in a testing group who received a dummy pill. But Merck has not publicly detailed the types of problems reported, which will be a key part of the FDA’s review.

Top U.S. health officials continue to push vaccinations as the best way to protect against COVID-19.

“It’s much, much better to prevent yourself from getting infected than to have to treat an infection,” Dr. Anthony Fauci said while discussing Merck’s drug last week.

Still, some 68 million eligible Americans remain unvaccinated, underscoring the need for effective drugs to control future waves of infection.

The prospect of a COVID-19 pill comes amid other encouraging signs: New cases per day in the U.S. have dropped below 100,000 on average for the first time in over two months, and deaths are running at about 1,700 a day, down from more than 2,000 three weeks ago.

Also, the average number of vaccinations dispensed per day has climbed past 1 million, an increase of more than 50% over the past two weeks, driven by the introduction of booster shots and workplace vaccine requirements.

Still, heath authorities are bracing for another possible surge as cold weather drives more people indoors.

Since the beginning of the pandemic, health experts have stressed the need for a convenient pill. The goal is for something similar to Tamiflu, the 20-year-old flu medication that shortens the illness by a day or two and blunts the severity of symptoms like fever, cough and stuffy nose.

Three FDA-authorized antibody drugs have proved highly effective at reducing COVID-19 deaths, but they are expensive, hard to produce and require specialty equipment and health professionals to deliver.

Assuming FDA authorization, the U.S. government has agreed to buy enough of the pills to treat 1.7 million people, at a price of roughly $700 for each course of treatment. That's less than half the price of the antibody drugs purchased by the U.S. government — over $2,000 per infusion — but still more expensive than many antiviral pills for other conditions.

Merck's Kartsonis said in an interview that the $700 figure does not represent the final price for the medication.

“We set that price before we had any data, so that's just one contract,” Kartsonis said. “Obviously we're going to be responsible about this and make this drug as accessible to as many people around the world as we can.”

Kenilworth, New Jersey-based Merck has said it is in purchase talks with governments around the world and will use a sliding price scale based on each country's economic means. Also, the company has signed licensing deals with several Indian generic drugmakers to produce low-cost versions of the drug for lower-income countries.

Several other companies, including Pfizer and Roche, are studying similar drugs and are expected to report results in the coming weeks and months. AstraZeneca is also seeking FDA authorization for a long-acting antibody drug intended to provide months of protection for patients who have immune-system disorders and do not adequately respond to vaccination.

Some experts predict various COVID-19 therapies eventually will be prescribed in combination to better protect against the worst effects of the virus.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Local/State News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Online Headlines - Washington, AP Health, AP Business, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
UK police won't act against Prince Andrew over abuse claim
British police will not be taking any further action against Prince Andrew after a review prompted by a Jeffrey Epstein accuser who claims that he sexually assaulted her
5:50AM ( 19 minutes ago )
Official says journalist's Nobel Prize not a slap on Duterte
Philippine President Rodrigo Duterte’s administration has belatedly congratulated journalist Maria Ressa for being one of two winners of this year’s Nobel Peace Prize
5:33AM ( 35 minutes ago )
Global shares mixed on energy worries, weak US jobs data
Global shares are mixed amid persisting worries about energy shortages and weaker than expected jobs growth in the U.S.  Shares fell in Paris, Frankfurt and Sydney but rose in Tokyo and London
5:27AM ( 41 minutes ago )
Associated Press (AP)
Huge fire breaks out at oil facility in southern Lebanon
State media reports that a huge fire has broken out at an oil facility in southern Lebanon, sending a thick column of smoke into the sky
4:22AM ( 1 hour ago )
Early results show record low turnout in Iraq's election
Iraq's electoral committee says preliminary results show turnout from Sunday’s election was 41 percent
4:19AM ( 1 hour ago )
Nobel panel to announce 2021 economics prize
The winner of the 2021 Nobel prize for outstanding work in the field of economics will be announced Monday
4:01AM ( 2 hours ago )
AP National News
García, Grandal shine as White Sox beat Astros 12-6 in ALDS
Leury García and Yasmani Grandal homered, and Grandal’s borderline baserunning helped the Chicago White Sox top the Houston Astros 12-6 to stay alive in their AL Division Series
1:23AM ( 4 hours ago )
Southern California beach set to reopen after oil spill
Officials say a Southern California beach that had been closed since an undersea pipeline leaked crude into ocean waters last week is set to reopen Monday
1:09AM ( 5 hours ago )
Ground Rule Trouble: Red Sox bounce Rays in 13 on odd call
The Boston Red Sox were saved by a lucky bounce that cost Tampa Bay a certain run and maybe more in Game 3 of the AL Division Series
12:30AM ( 5 hours ago )
Top General short headlines
Sydney opens to vaccinated after 100-plus days of lockdown
Sydney hairdressers, gyms, cafés and bars have reopened to fully vaccinated customers for the first time in more than 100 days after Australia’s largest city achieved a vaccination benchmark
9:02PM ( 9 hours ago )
Calls rise in Italy to ban pro-fascism groups after rampage
Some politicians in Italy are calling for a ban on pro-fascism groups after anti-vaccine protesters, incited by leaders of the extreme right, stormed a union office in Rome
2:42PM ( 15 hours ago )
The Latest: Fauci says fine to trick-or-treat this year
The government’s top infectious diseases expert says families can feel safe trick-or-treating outdoors this year for Halloween as COVID-19 cases in the U.S. decline, especially for those who are vaccinated
11:56AM ( 18 hours ago )
AP Health
Bing Crosby's heirs sell stake in estate to boost his work
It's not just old rock stars benefiting from the current trend of artists selling off rights to their work
6:00AM ( 10 minutes ago )
Flooding sends bus into river in China; 120,000 evacuated
A bus has fallen into a river in northern China, leaving at least three people dead and 11 others missing after flooding from heavy rains destroyed homes and covered farmland
4:19AM ( 1 hour ago )
Asian shares mostly higher despite lingering energy worries
Asian shares are mostly higher despite persisting worries about the region's energy crunch and coronavirus infections
2:27AM ( 3 hours ago )
AP Business
EXPLAINER: How US states help rich foreigners shield assets
A mention of “tax havens” typically conjures images of sun-soaked Caribbean escapes like the Cayman Islands or the buttoned-down banks of Switzerland
3:01PM ( 15 hours ago )
Czech president hospitalized; Could affect forming new govt
Czech President Milos Zeman has been rushed to the hospital a day after a parliamentary election in which he has a key role in establishing a new government
2:54PM ( 15 hours ago )
The Latest: Marchers in Rome protest work vaccine rule
Thousands of demonstrators marched down Rome’s main streets, some clashing with police, to protest a government rule requiring COVID-19 vaccines or negative tests to access workplaces next week
1:46PM ( 1 day ago )
AP Business - Industries
Texas moves to reinstate nation's toughest abortion law
Texas has asked a federal appeals court to swiftly reinstate the most restrictive abortion law in the U.S. The request comes Friday as some abortion clinics in the state resumed normal services for the first time since early September
6:22PM ( 2 days ago )
The Latest: Pennsylvania virus cases rise among vaccinated
The proportion of coronavirus infections and hospitalizations among vaccinated Pennsylvania residents has risen sharply in the past month, although the shots remain broadly protective
3:27PM ( 2 days ago )
The Latest: Panel to meet on shots for ages 5-11 next month
A panel of vaccine experts will meet in early November to consider whether to recommend the Pfizer COVID-19 vaccine for children younger than 12
1:58PM ( 2 days ago )
AP Business - Health Care
UK police won't act against Prince Andrew over abuse claim
British police will not be taking any further action against Prince Andrew after a review prompted by a Jeffrey Epstein accuser who claims that he sexually assaulted her
5:50AM ( 20 minutes ago )
Official says journalist's Nobel Prize not a slap on Duterte
Philippine President Rodrigo Duterte’s administration has belatedly congratulated journalist Maria Ressa for being one of two winners of this year’s Nobel Peace Prize
5:33AM ( 37 minutes ago )
Global shares mixed on energy worries, weak US jobs data
Global shares are mixed amid persisting worries about energy shortages and weaker than expected jobs growth in the U.S.  Shares fell in Paris, Frankfurt and Sydney but rose in Tokyo and London
5:27AM ( 43 minutes ago )
Fiona Hill, a nobody to Trump and Putin, saw into them both
Fiona Hill was Donald Trump’s Russia adviser and a central figure in his first presidential impeachment
5:27AM ( 43 minutes ago )
Huge fire extinguished at oil facility in southern Lebanon
Firefighters have extinguished a huge blaze that broke out in a storage tank at one of Lebanon’s main oil facilities in the country’s south
5:27AM ( 43 minutes ago )